Life Sciences Research for Lifelong Health

The Babraham Institute announces the formation of Babraham Commercialisation Services Ltd

The Babraham Institute has announced the formation of a new wholly-owned trading arm, Babraham Commercialisation Services Ltd (BCS), to support its Knowledge Exchange and Commercialisation (KEC) activities.

Babraham’s KEC Programme aims to maximise the social and economic benefits of its biological research by building links with other researchers, research charities, clinicians, biotechnology and pharmaceutical companies, policy makers and the public. Many of the academics at the Babraham Institute, which receives strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC), collaborate with pharmaceutical and biotechnology companies through shared research projects, consultancy or providing access to scientific facilities and services.

The Babraham Institute’s research has resulted in the development of several innovative new technologies, such as those that were spun out of the Institute to form Crescendo Biologics Ltd.  BCS will now be responsible for managing and commercialising the intellectual property portfolio of the Institute, as well as facilitating its interactions with industry, and will be led in these activities by Dr Katy Evans-Roberts, Commercialisation Manager.

This reorganisation will also allow Babraham Bioscience Technologies Ltd (BBT) to focus on the development of the Babraham Research Campus, a thriving community at the heart of the Cambridge cluster which is now home to around 45 biomedical companies.  The campus is currently expanding as a result of the £44 million BBSRC project announced by Government in 2011 - an investment in capital infrastructure to support bioscience innovation. The campus’ new chemistry-focused building, which opened last month and is now 80% occupied, provides 16,000 sq ft of lettable space to companies including Cancer Research Technology Limited (CRT), the cancer-focused technology development and commercialisation arm of Cancer Research UK.  

CONTACT Dr Katy Evans-Roberts Commercialisation Manager, +44 (0)1223 496208  


20 May, 2013